Evidence map›Paper›PMID 38717575›Full record

ArticleMikrochimica acta2024

Development of a time-resolved immunochromatographic test strip for rapid and quantitative determination of retinol-binding protein 4 in urine.

Wenjie Guo, Zhiyong Yu, Tianxu Li, Lingfei Lu, Huiqi Lin, Ying Liao, Yanghao Zheng, Yuntao Liu, Glaskovich Maria Alevtinovna, Dzmitry S Barysavets and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Wenjie Guo *School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, Guangdong, China.
Zhiyong Yu *School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, Guangdong, China.
Tianxu LiSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, Guangdong, China.
Lingfei LuDepartment of Nephrology, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, 518033, Guangdong, China.
Huiqi LinSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, Guangdong, China.
Ying LiaoSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, Guangdong, China.
Yanghao ZhengSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, Guangdong, China.
Yuntao LiuThe Second Affiliated Hospital of Guangzhou, Guangdong Provincial Key Laboratory of Research on Emergency in TCM, University of Chinese Medicine, Guangzhou, Guangdong, China.
Glaskovich Maria AlevtinovnaInstitute of Experimental Veterinary Medicine named of S.N. Vyshelessky, Minsk, Belarus.
Dzmitry S BarysavetsInstitute of Experimental Veterinary Medicine named of S.N. Vyshelessky, Minsk, Belarus.
Jinping ChenInstitute of Zoology, Guangdong Academy of Sciences, Guangzhou, Guangdong, China.
Jie ZanSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, Guangdong, China. zanj@gdut.edu.cn.
Jiandong LuDepartment of Nephrology, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, 518033, Guangdong, China. lujiandong@yeah.net.

Funding

Science and Technology Planning Project of Guangdong Province No. 2023B1212060062Shenzhen Science and Technology Innovation Program No. JCYJ20220531092201003
6 · The paper itself

Abstract

Urine retinol-binding protein 4 (RBP4) has recently been reported as a novel earlier biomarker of chronic kidney disease (CKD) which is a global public health problem with high morbidity and mortality. Accurate and rapid detection of urine RBP4 is essential for early monitor of impaired kidney function and prevention of CKD progression. In the present study, we developed a time-resolved fluorescence immunochromatographic test strip (TRFIS) for the quantitative and rapid detection of urine RBP4. This TRFIS possessed excellent linearity ranging from 0.024 to 12.50 ng/mL for the detection of urine RBP4, and displayed a good linearity (Y = 239,581 × X + 617,238, R

Indexed as

Chromatography, AffinityRenal Insufficiency, ChronicRetinol-Binding Proteins, PlasmaBiomarkersHumansImmunoassayLimit of DetectionReagent StripsBiomarkersRBP4 protein, humanReagent StripsRetinol-Binding Proteins, PlasmaChronic kidney diseaseFluorescence test stripRetinol-binding protein 4Urine analysis

Identifiers

PMID38717575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.